Interview with Makoto Tahara, MD, PhD | Japan - Prova Education

Interview with Makoto Tahara, MD, PhD | Japan

Interview with Makoto Tahara, MD, PhD | Japan

10

10

Overview
While at the 2015 ECC conference in Vienna, Austria, Dr. Makoto Tahara spoke with us about what he thought were the best presentations and posters from the conference, and what was emerging in induction therapy and maintenance in head and neck cancer. We also discussed what is on the horizon for biomarkers and treating HPV and non-HPV related cancers of the head and neck.

Facebook Comments

Recommended

- Mark Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
0
CME/CE
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
0.25 credits
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunothe...
0.25 credits
- Daniel P. Petrylak, MD
  Peer
- Arlene O. Siefker-Radtke, MD
  Peer
2
CME/CE
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
0.25 credits
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or...
0.25 credits
- Lauren Ritterhouse, MD ,PhD
  Peer
- Pasi Antero Jänne, MD, PhD
  Peer
- Kanwal Raghav, MD
  Peer
1
CME/CE
The Role of HER3 Expression in Advanced Solid Tumors
The Role of HER3 Expression in Advanced Solid Tumors
0.50 credits
The Role of HER3 Expression in Advanced Solid Tumors
0.50 credits
- Mark Socinski, MD
  Peer
- John V. Heymach, MD, PhD
  Peer
1
CME/CE
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC
0.25 credits
Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGF...
0.25 credits